CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
factor ixdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000582
NCT00000582Phase 3Completed
CompareCT.gov

Cooperative Study of Factor VIII Inhibitors

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Apr 27, 2012

In Brief

A Phase 3 clinical trial evaluating factor ix for Blood Coagulation Disorders and 3 related conditions. Completed.

Detailed Summary

To test the efficacy of prothrombin complex concentrates (Factor IX) in the treatment of hemophiliac patients who had inhibitors to Factor VIII.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBlood Coagulation Disorders, Hematologic Diseases, Hemophilia A, Hemorrhagic Disorders
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
19781979198019811982198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartJul 1, 1978
Study CompletionJul 1, 1979
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

factor ixdrug